Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02348814 · ClinicalTrials.gov registry record
Development of a Novel Biomarker for Liver Fibrosis
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 25
- Enrollment target
NCT02348814 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 25 participants.
The verdict
NCT02348814 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The overall aim of this study is to validate a quantitative digital tool for staging liver fibrosis in biopsies from chronic human liver diseases and then evaluate it prospectively in patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02348814
The ClinicalTrials.gov registry entry for NCT02348814 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02348814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02348814 about?
NCT02348814 is a clinical study titled "Development of a Novel Biomarker for Liver Fibrosis". The overall aim of this study is to validate a quantitative digital tool for staging liver fibrosis in biopsies from chronic human liver diseases and then evaluate it prospectively in patients.
What is the current status of trial NCT02348814?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-05. Estimated completion is 2019-02-26.
Who is sponsoring clinical trial NCT02348814?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.